Clinical Trial Update: Randomized Trial of Maternal Progesterone Therapy [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating maternal progesterone therapy for fetal/neonatal outcomes in pregnancies at risk for congenital heart disease and brain in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Development
• Congenital Heart Disease
• Neurodevelopmental Disability
• Periventricular Leucomalacia

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Congenital Heart Disease, Periventricular Leucomalacia | Phase 2 | Status: COMPLETED | Results posted: 2023-02-28